Download curriculum vitae - Georgetown University

CURRICULUM VITAE
PERSONAL DATA
Francisco Bracho, MD
Department of Pediatrics
Division of Pediatric Hematology/Oncology
Lombardi Cancer Center
Georgetown University Hospital
3800 Reservoir Rd
Washington DC 20007
EDUCATION
1984-1989
University of California at Los Angeles, CA Bachelor of Science,
Microbiology
1989-1993
University of California at Los Angeles School of Medicine, Doctor
of Medicine
1993-1996
University of Southern California, Dept of Pediatrics Pediatric
Resident
POST DOCTORAL TRAINING
1996-1998
1998-1999
APPOINTMENT
2000-present
RESEARCH
2003-present
2004-present
2000-present
Children’s Hospital Orange County California Fellow,
Hematology/Oncology
Pediatric Branch National Cancer Institute, Basic Research at
Georgetown University Medical Center, Fellow
Hematology/Oncology
Assistant Professor of Clinical Pediatrics, Georgetown University
Hospital
Principal Investigator, US. A Randomized, Double Blind, Placebocontrolled, Multicenter Study of a Subcutaneous Formulation of
Icatibant for the Treatment of Hereditary Angioedema. Sponsor
Jerini AG
Principal Investigator. GUH. A randomized, placebo-controlled,
doubleblind Phase II study of the safety and efficacy of recombinant
human C1 inhibitor for the treatment of acute attacks in patients
with hereditary angioedema. Sponsor Pharming NV
Co-Investigator, GUH. Children’s Oncology Group
2006
GRANT
2004
Principal Investigator GUH, Expanded Access Protocol: Safety and
Efficacy of Varicella Zoster Immune Globulin (Human) (VariZIG™)
in Patients At-Risk of Varicella Infection. Sponsor Cangene Corp.
Jerini AG Principal Investigator, US. A Randomized, Double Blind,
Placebo-controlled, Multicenter Study of a Subcutaneous
Formulation of Icatibant for the Treatment of Hereditary
Angioedema
CERTIFICATION:
Medical License, District of Columbia # MD313355
Medical License, California (1993-1998)
1993
Diplomate National Board of Medical Examiners
1996&2003
Diplomate National Board of Pediatrics
2002
Diplomate Subboard Pediatric Hematology/Oncology
HONORS & AWARDS:
1984-1993
1989
1989
1992
1992
1993
1994
1998
Regent’s Scholar University of California (Awarded as
undergraduate and Medical Student)
Magna cum Laude University of California, Los Angeles
Phi Beta Kappa, UCLA
McLean Scholar, National Medical Fellowships
Awardee National Hispanic Scholarship Fund
Alpha Omega Alpha, UCLA SOM
Recognition of Service to Community, UCLA Chicano Latino
Medical Student Association
Awarded Clinical Oncology Research Training Program Grant
(K12), Lombardi Cancer Center
TEACHING ACTIVITIES
2000-present
Lecturer First Year: Clinical Correlate, Sickle Cell Anemia,
Biochemistry, Georgetown University School of Medicine
2001-present
Lecturer Second Year: Hematopoiesis and hematologic disorders,
Pathology, Georgetown University School of Medicine
COMMITTEE AND ADMINISTRATIVE SERVICE
2000—Present
Member Clinical Research Committee, Lombardi Cancer Center
2000—Present
Chair, Pediatric Tumor Board
2000—Present
Quality Assurance, Pediatric Inpatient Floor
2004—Present
Medical Board, Childhood Brain Tumor Foundation
2005—Present
Member, MedStar Oncology Institutional Review Board
PUBLICATIONS:
1. Bracho F. Hereditary angioedema. Curr Opin Hematol. 2005 Nov;12(6):493-8.
Review
2. Bracho F, van de Ven C, Areman E, Hughes RM, Davenport V, Bradley MB, Cai
JW, Cairo MS. A comparison of ex vivo expanded DCs derived from cord blood
and mobilized adult peripheral blood plastic-adherent mononuclear cells:
decreased alloreactivity of cord blood DCs. Cytotherapy. 2003;5(5):349-61.
3. Goldman SC, Bracho F, Davenport V, Slack R, Areman E, Shen V, Lanarsky C,
Weinthal J, Hughes R. Cairo MS. Feasibility study of IL-II and granulocyte
colony-stimulating factor after myelosuppressive chemotherapy to mobilize
peripheral blood stem cells from heavily pretreated patients. J Pediatr Hematol
Oncol. 2001 Jun-Jul;23 (5):300-5.
4. Houtenbos I, Bracho F, Devenport V, Slack R, van de Ven C, Suen Y, Killen R,
Shen V, Cairo MS. Autologous bone marrow transplantation for childhood acute
lymphoblastic leukemia: a novel combined approach consisting of ex vivo
marrow purging, modulation of multi-drug resistance, induction of autograft vs
leukemia effect, and post-transplant immuno-and chemotherapy (PTIC). Bone
Marrow Transplant 2001 Jan;27 (2):145-53.
5. Bracho F, Krailo MD, Shen V. Bergeron S, Davenport V, Liu-Marces W, Blazer
BR, Panoskaltsis-Mortari A. van de Ven C, Secola R, Ames MM, Reid JM,
Reaman GH, Cairo MS. A phase I clinical, pharmacological, and biological trial
of interleukim 6 plus granulocyte-colony stimulating factor after ifosfamide,
carboplatin, and etoposide in children with recurrent/refractory solid tumors:
enhanced hematological responses but a high incidence of grade III/IV
constitutional toxicities. Clin Cancer Res. 2001 Jan;7(1):58-67.
6. Loh K, Matthay KK, Hoover M, Bracho FA, Cortez AB, Conte FA, Albanese CT,
Miller TR, Price DC, Vlores AJ, Kaviani A, Shoback D. Hypercalcemia in
malignant paraganglioma due to parathyroid hormone related protein. Horm Res.
1998;50(4):217-21.
7. Bracho F, Goldman S, Cairo MD. Potential use of granulocyte colony-stimulating
factor and granulocyte-macrophage colony-stimulating factor in neonates. Curr
Opin Hematol. 1998 May; 5(3):215-20. Review.
8. Koo CH, Shin SS, Bracho F, Johnston WH, Rappaport H. Rosette-forming nonHodgkin’s lymphomas. Histopathology. 1996 Dec;29(6):557-63